MCID: RNV001
MIFTS: 47

Renovascular Hypertension malady

Categories: Cardiovascular diseases, Nephrological diseases

Aliases & Classifications for Renovascular Hypertension

About this section

Aliases & Descriptions for Renovascular Hypertension:

Name: Renovascular Hypertension 11 13
Hypertension, Renovascular 39 68
 
Hypertension Renovascular 50

Classifications:



External Ids:

Disease Ontology11 DOID:1591
ICD1030 I15.0
MeSH39 D006978
NCIt45 C85044

Summaries for Renovascular Hypertension

About this section
Wikipedia:71 Renovascular hypertension (or \"renal hypertension\") is a condition in which high blood pressure is... more...

MalaCards based summary: Renovascular Hypertension, also known as hypertension, renovascular, is related to malignant renovascular hypertension and benign renovascular hypertension. An important gene associated with Renovascular Hypertension is REN (Renin), and among its related pathways are Endothelin Pathways and Validated transcriptional targets of AP1 family members Fra1 and Fra2. The drugs fenoldopam and fenoldopam mesylate have been mentioned in the context of this disorder. Affiliated tissues include kidney, endothelial and testes, and related mouse phenotypes are liver/biliary system and endocrine/exocrine gland.

Related Diseases for Renovascular Hypertension

About this section

Diseases in the Renovascular Hypertension family:

Benign Renovascular Hypertension Malignant Renovascular Hypertension

Diseases related to Renovascular Hypertension via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 170)
idRelated DiseaseScoreTop Affiliating Genes
1malignant renovascular hypertension12.2
2benign renovascular hypertension12.0
3uterine inflammatory disease10.3EDN1, REN
4hypotrichosis simplex10.3ACE, REN
5hyperinsulinemic hypoglycemia, familial, 310.3ACE, REN
6carbohydrate metabolic disorder10.3ACE, REN
7hypothyroidism, congenital nongoitrous, 510.3ACE, REN
8hepatic infarction10.3EDN1, REN
9listeriosis10.3ACE, REN
10dientamoebiasis10.3ACE, REN
11adenocarcinoma10.3EDN1, REN
12endotheliitis10.3
13proliferating trichilemmal cyst10.3EDN1, NOS3
14congenital nystagmus10.3ACE, REN
15shaken baby syndrome10.3NPPA, REN
16kartagener syndrome10.2ACE, NOS3
17achromatopsia10.2NPPA, REN
18blackwater fever10.2EDN1, NPPA
19indeterminate leprosy10.2EDN1, NOS3
20fibromuscular dysplasia10.2
21chylocele of tunica vaginalis10.2ACE, REN
22hypogonadism mitral valve prolapse mental retardation10.2ACE, NPPA, REN
23chronic inflammatory demyelinating polyneuropathy10.2NPPB, REN
24high-grade dysplasia in patients with barrett esophagus10.2EDN1, NPPA, REN
25bullous skin disease10.2ACE, HMOX1
26pythiosis10.2ACE, NPPA, REN
27capillary hemangioma10.2EDN1, NOS3, REN
28aphasia10.2ACE, EDN1, NOS3
29oppositional defiant disorder10.1ACE, EDN1, NOS3
30gastrointestinal lymphoma10.1ACE, NOS3, REN
31citrulline transport defect10.1EDN1, NPPB
32rapidly progressive glomerulonephritis10.1ACE, NOS3, NPPA
33viral hepatitis10.1ACE, EDN1, NOS3
34peroneal neuropathy10.1ACE, NOS3, REN
35hemorrhoid10.1EDN1, REN
36body dysmorphic disorder10.1ACE, NOS3, REN
37lymphoblastic lymphoma10.1EDN1, NPPA, REN
38autonomic neuropathy10.1NPPB, REN
39aneurysm10.1
40zellweger syndrome10.1EDN1, HMOX1, NOS3
41takayasu arteritis10.1
42neurofibromatosis10.1
43vitreous disease10.1NOS3, NPPB
44myopia10.1ACE, EDN1, NPPA, REN
45autoimmune-related retinopathy and optic neuropathy10.1ACE, EDN1, NOS3
46ischemia10.1
47limb ischemia10.1ACE, EDN1, NOS3, REN
48deafness, autosomal recessive 7910.1ACE, NPPB, REN
49inferolateral myocardial infarct10.1ACE, NPPA, NPPB
50urinary bladder posterior wall cancer10.0NPPA, NPPB, REN

Graphical network of the top 20 diseases related to Renovascular Hypertension:



Diseases related to renovascular hypertension

Symptoms & Phenotypes for Renovascular Hypertension

About this section

MGI Mouse Phenotypes related to Renovascular Hypertension according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053709.2ACE, ADM, HMOX1, NF1, NOS3
2MP:00053798.9ACE, ADM, EDN1, HMOX1, NF1, NOS3
3MP:00053698.5ADM, EDN1, HMOX1, NF1, NOS3, NPPA
4MP:00053857.8ACE, ADM, AGTR1, EDN1, HMOX1, NF1
5MP:00053877.8ACE, ADM, AGTR1, CMA1, HMOX1, NF1
6MP:00053767.7ACE, ADM, AGTR1, EDN1, HMOX1, NF1
7MP:00053977.5ACE, ADM, AGTR1, CMA1, HMOX1, NF1
8MP:00053676.9ACE, ADM, AGTR1, EDN1, HMOX1, NF1

Drugs & Therapeutics for Renovascular Hypertension

About this section

Drugs for Renovascular Hypertension (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 48)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1Hydroxymethylglutaryl-CoA Reductase InhibitorsPhase 4, Phase 31998
2Antihypertensive AgentsPhase 4, Phase 34207
3
CandesartanapprovedPhase 3157139481-59-72541
Synonyms:
139481-59-7
2-(ethyloxy)-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid
2-Ethoxy-1-(P-(O-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid
2-Ethoxy-1-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid
2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid
2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4ethyl]}-1H-benzimidazole-7-carboxylic acid
2-Ethoxy-3-[[4-[2-(1H-tetrazol-5-yl)phenyl]phenyl] methyl]-3H-benzoimidazole-4-carboxylic acid
2-ethoxy-1-({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl)-1H-benzimidazole-7-carboxylic acid
2-ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid
2-ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4ethyl}-1H-benzimidazole-7-carboxylic acid
2-ethoxy-3-[[4-[2-(1h-tetrazol-5-yl)phenyl]phenyl]methyl]-3h-benzoimidazole-4-carboxylic acid
2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylic acid
2-ethoxy-7-carboxy-1-(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methylbenzimidazole
AC-203
AC1L1DWT
Amias
Atacand
Atacand, Blopress, Amias, Ratacand,Candesartan
BIDD:GT0350
Blopress
Blopress (TN)
C07468
C081643
C24H20N6O3
CHEBI:216848
 
CHEBI:3347
CHEMBL1016
CID2541
CV 11974
CV-11974
CV11974
Candesartan (USAN/INN)
Candesartan [BAN]
Candesartan [USAN:INN]
Candesartan cilexetil
D00522
DB00796
FT-0083585
HMS2089M22
HSDB 7520
I01-0374
KS-5003
L000156
LS-32740
MolPort-003-845-570
MolPort-005-943-739
NCGC00167474-01
Ratacand
S1578_Selleck
TL8000897
UNII-S8Q36MD2XX
candesartan
4
AmlodipineapprovedPhase 349688150-42-92162
Synonyms:
()-Amlodipine
(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
-3-(ethoxycarbonyl)-5-(methoxycarbonyl)-6-methyl-1,4-dihydropyridine
2-[(2-Aminoethoxy)methyl]-4-(2-chlorophenyl)
3,5-Pyridinedicarboxylic acid, 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester
3,5-Pyridinedicarboxylic acid, 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester
3-Ethyl 5-methylester, (±)-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-Ethyl-5-methyl ( -)-2-((2-aminoethoxy)methyl)-4-(2-chlorphenyl)-1,4-dihydro-6-methyl-3,5-pyridindicarboxylat
3-Ethyl-5-methyl ( -)-2-((2-aminoethoxymethyl)-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-Ethyl-5-methyl (.+/-.)-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-O-ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
3-ethyl 5-methyl 2-{[(2-aminoethyl)oxy]methyl}-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
88150-42-9
88150-47-4 (maleate (1:1))
AC-4535
AC1L1D26
AC1Q32ZS
AMLODIPINE BASE
AMVAZ
Ambap88150-42-9
Amlocard
Amlodipine
Amlodipine (INN)
Amlodipine Benzenesulfonate
Amlodipine Besilate
Amlodipine Besylate
Amlodipine Free Base
Amlodipine [INN:BAN]
Amlodipine besilate
Amlodipine besylate
Amlodipine free base
Amlodipino
Amlodipino [Spanish]
Amlodipinum
Amlodipinum [Latin]
Amlodis
Amlopres
Amlor
 
Amvaz
BIDD:GT0810
BRD-A22032524-074-02-4
BRD-A22032524-074-03-2
BSPBio_002727
C06825
CHEBI:2668
CHEMBL1491
CID2162
CPD000469198
Coroval
D07450
DB00381
HMS2052N03
HMS2089H07
I14-0798
Intervask
Istin
KBio3_001947
KBioGR_001643
LS-131183
Lipinox
Lotrel
MLS001401409
MolPort-001-792-963
NCGC00165957-01
NCGC00165957-02
NCGC00165957-03
Norvasc
Norvasc (TN)
Pelmec
R,S)-Amlodipine
Racemic Amlodipine
SAM001246705
SMR000469198
SPBio_000351
Spectrum2_000486
Spectrum3_001004
Spectrum4_001132
Spectrum5_001550
UK-4834011
UNII-1J444QC288
amlodipine
5
Celecoxibapproved, investigationalPhase 3444169590-42-52662
Synonyms:
169590-42-5
184007-95-2
1oq5
4-(5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide
4-[5-(4-METHYLPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]BENZENESULFONAMIDE
4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1Hpyrazol-1-yl] benzenesulfonamide
4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide
AC-4228
AC1L1E6K
AI-525
BIDD:GT0408
BRD-K02637541-001-02-4
BSPBio_003596
Benzenesulfonamide,4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)
C07589
C105934
C17H14F3N3O2S
CCRIS 8679
CEL
CEP-33222
CHEBI:41423
CHEMBL118
CID2662
CPD000550473
Celebra
Celebrex
Celebrex (TN)
Celebrex, Celebra, Celecoxib
Celecox
Celecoxi
Celecoxib
Celecoxib (JAN/USAN/INN)
Celecoxib (SC-58635)
Celecoxib [Old RN]
Celecoxib [USAN]
Celecoxibum
Celocoxib
Célécoxib
D00567
DB00482
DivK1c_000893
Eurocox
FT-0080064
HMS1922G14
HMS2089L18
HMS2093I07
HMS502M15
HSDB 7038
I01-1033
IDI1_000893
KBio1_000893
KBio2_000912
 
KBio2_002351
KBio2_003480
KBio2_004919
KBio2_006048
KBio2_007487
KBio3_002830
KBio3_003037
KBioGR_000723
KBioGR_002351
KBioSS_000912
KBioSS_002354
LS-31667
MLS001165684
MLS001195656
MLS001304708
Medicoxib
MolPort-002-885-815
NCGC00091455-01
NCGC00091455-02
NCGC00091455-03
NCGC00091455-04
NCI60_041049
NINDS_000893
NSC719627
Onsenal
P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide
Pfizer brand of celecoxib
S1261_Selleck
SAM002589995
SC 58635
SC-58553, SC-58635
SC-58635
SC58635
SMR000550473
SPBio_001512
SPECTRUM1503678
Solexa
Spectrum2_001576
Spectrum3_001996
Spectrum4_000182
Spectrum5_001324
Spectrum_000432
TL8001323
TPI-336
UNM-0000305813
Xilebao
YM 177
YM-177
YM177
ZINC02570895
cMAP_000027
celecoxib
p-(5-p-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide
6Calcium, DietaryPhase 35713
7calcium channel blockersPhase 31985
8Lipid Regulating AgentsPhase 32766
9Hypolipidemic AgentsPhase 32785
10
Candesartan cilexetilPhase 3157145040-37-52540
Synonyms:
(+-)-1-Hydroxyethyl 2-ethoxy-1-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylate, cyclohexyl carbonate (ester)
1-(cyclohexylocarbonyloxy)ethyl-2-ethoxy-1-(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)-1H-benzimidazole-7-carboxylate
1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate
1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-(ethyloxy)-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate
145040-37-5
1H-Benzimidazole-7-carboxylic acid, 2-ethoxy-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester
2-Ethoxy-3-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-benzoimidazole-4-carboxylic acid 1-cyclohexyloxycarbonyloxy-ethyl ester
2-ethoxy-3-[2'-(1h-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3h-benzoimidazole-4-carboxylic acid 1-cyclohe
AC-204
AC1L1DWQ
ATACAND HCT
Almirall brand of candesartan cilexetil
Amias
Astra brand of candesartan cilexetil
AstraZeneca brand of candesartan cilexetil
Atacand
Atacand (TN)
BRD-A65671304-001-02-6
BSPBio_002691
C07709
C077793
C33H34N6O6
CHEBI:216349
CHEMBL1014
CID2540
Candesartan cilexetil
Candesartan cilexetil (JAN/USAN)
Candesartan cilexetil [USAN]
Candesartan hexetil
D00626
FT-0082579
H212/91
 
HMS1922J09
HMS2093E20
I06-0090
KBio2_002187
KBio2_004755
KBio2_007323
KBio3_001911
KBioGR_001607
KBioSS_002187
Kenzen
L006257
LS-32741
MolPort-003-666-552
NCGC00095123-01
NCGC00095123-02
NCGC00095123-03
Parapres
Promed brand of candesartan cilexetil
Racanda
SPBio_000349
SPECTRUM1504261
ST51052687
Spectrum2_000485
Spectrum3_000996
Spectrum4_001124
Spectrum5_001462
Spectrum_001707
TCV 116
TCV-116
TL8000995
Takeda brand of candesartan cilexetil
UNII-R85M2X0D68
candesartan cilexitil
11Atorvastatin CalciumPhase 3760134523-03-8
12
Angiotensin IIPhase 3117868521-88-0, 11128-99-765143, 172198
Synonyms:
1-8-Angiotensin I
1-L-Aspasaginyl-5-L-valyl angiotensin octapeptide
Ang II
Angiotensin 2
Angiotensin II (human)
 
Angiotensin II (mouse)
Angiotonin
Asp-arg-val-TYR-ile-his-pro-phe
Human angiotensin II
Hypertensin
Ile(5)-angiotensin II
13Amlodipine, atorvastatin drug combinationPhase 318
14AntimetabolitesPhase 312054
15Angiotensin II Type 1 Receptor BlockersPhase 31091
16Anticholesteremic AgentsPhase 32025
17Angiotensin Receptor AntagonistsPhase 31191
18AngiotensinogenPhase 31177
19Cyclooxygenase InhibitorsPhase 32870
20Vasodilator AgentsPhase 33543
21Peripheral Nervous System AgentsPhase 323689
22Cyclooxygenase 2 InhibitorsPhase 3624
23AnalgesicsPhase 311733
24Antirheumatic AgentsPhase 310956
25Analgesics, Non-NarcoticPhase 36501
26Anti-Inflammatory AgentsPhase 310729
27Anti-Inflammatory Agents, Non-SteroidalPhase 34443
28
Spironolactoneapproved2321952-01-7, 52-01-75833
Synonyms:
4-18-00-01601 (Beilstein Handbook Reference)
4-Pregnen-21-oic acid-17alpha-ol-3-one-7alpha-thiol gamma-lactone 7-acetate
496916-40-6
52-01-7
7-alpha-Acetylthio-3-oxo-17-alpha-pregn-4-ene-21,17-beta-carbolactone
7alpha-(acetylsulfanyl)-3-oxo-17alpha-pregn-4-ene-21,17-carbolactone
AB00513806
AC-4214
AC1L1L8Q
Abbolactone
Acelat
Aldace
Aldactazide
Aldactide
Aldactone
Aldactone (TN)
Aldactone A
Alderon
Aldopur
Almatol
Alphapharm Brand of Spironolactone
Alpharma Brand of Spironolactone
Alter Brand of Spironolactone
Altex
Aquareduct
Ashbourne Brand of Spironolactone
Azupharma Brand of Spironolactone
BIDD:PXR0071
BPBio1_000194
BRD-K90027355-001-03-4
BRN 0057767
BSPBio_000176
C07310
C24H32O4S
CHEBI:428201
CHEBI:45692
CHEBI:9241
CHEMBL1393
CID5833
CPD000471892
Cardel Brand of Spironolactone
D00443
D013148
DB00421
Deverol
Dexo Brand of Spironolactone
Diatensec
Dira
Duraspiron
EINECS 200-133-6
Espironolactona
Espironolactona Alter
Espironolactona Mundogen
Espironolactona [INN-Spanish]
Euteberol
Flumach
Frumikal
Generosan Brand of Spironolactone
HMS1568I18
HMS2090N21
HSDB 3184
Hormosan Brand of Spironolactone
I06-1970
Jenapharm Brand of Spironolactone
Jenaspiron
LS-118614
LT00772287
Lacalmin
Lacdene
Laractone
MLS001074672
MLS001333253
MLS001333254
MLS002153245
MLS002207058
Mayoly-Spindler Brand of Spironolactone
Melarcon
Merck dura Brand of Spironolactone
Mundogen Brand of Spironolactone
NCGC00164397-01
 
NCGC00164397-02
NSC 150399
NSC150399
Nefurofan
Novo Spiroton
Novo-Spiroton
NovoSpiroton
Novopharm Brand of Spironolactone
Osyrol
Pfizer Brand of Spironolactone
Pharmafrid Brand of Spironolactone
Practon
Prestwick0_000128
Prestwick1_000128
Prestwick2_000128
Prestwick3_000128
Roche Brand of Spironolactone
S0260
S3378_SIGMA
SAM002264648
SC 9420
SC-9420
SC9420
SMR000471892
SNL
SPBio_002115
Sagisal
Searle Brand of Spironolactone
Sincomen
Spiractin
Spiresis
Spiretic
Spiridon
Spiro L.U.T.
Spiro(17H-cyclopenta(a)phenauthrene-17,2'-(3'H)-furan)
Spiro-Tablinen
Spiro[17H-cyclopenta[a]phenauthrene-17,2'-(3'H)-furan]
Spirobeta
Spiroctan
Spiroctanie
Spiroderm
Spirogamma
Spirolactone
Spirolakton
Spirolang
Spirolone
Spirone
Spirono Isis
Spirono-Isis
Spironocompren
Spironolactone
Spironolactone (JP15/USP/INN)
Spironolactone A
Spironolactone [BAN:INN:JAN]
Spironolactone [INN:BAN:JAN]
Spironolactonum
Spironolactonum [INN-Latin]
Spironolattone
Spironolattone [DCIT]
Spironone
Spirospare
Sprioderm
Supra-puren
Suracton
UNII-27O7W4T232
Uractone
Urusonin
Veroshpiron
Verospiron
Verospirone
Verospirone Opianin
WLN: L E5 B666 FX OV MUTJ A1 E1 KSV1 F-& CT5VOXTJ
Worwag Brand of Spironolactone
Xenalon
ZINC03861599
betapharm Brand of Spironolactone
ct Arzneimittel Brand of Spironolactone
ct-Arzneimittel Brand of Spironolactone
spiro von ct
spironolactone
spironolattone
von ct, spiro
29
Amilorideapproved532016-88-8, 2609-46-316231
Synonyms:
17440-83-4 (hydrochloride)
1f5l
2016-88-8 (anhydrous hydrochloride)
2609-46-3
3,5-Diamino-N-(aminoiminomethyl)-6-chloropyrazinecarboxamide
3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide
3,5-diamino-6-chloro-N-(diaminomethylidene)pyrazine-2-carboxamide
3,5-diamino-N-[amino(imino)methyl]-6-chloropyrazine-2-carboxamide
3,5-diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide
AB00053415
AC-13631
AC1L27IZ
AC1Q3POC
AMILORIDE
AMILORIDE (SEE ALSO: AMILORIDE HCL (2016-88-8))
Amiclaran
Amiclaran (TN)
Amikal (Hydrochloride dihydrate)
Amilorid
Amilorida
Amilorida [INN-Spanish]
Amiloride (INN)
Amiloride HCL
Amiloride [INN:BAN]
Amiloride hydrochloride hydrate
Amiloridum
Amiloridum [INN-Latin]
Amipramidin
Amipramidine
Amipramizid
Amipramizide
Amiprazidine
Amyloride
BCBcMAP01_000101
BIDD:GT0466
BPBio1_000015
BRD-K97181089-003-02-3
BRD-K97181089-310-03-0
BSPBio_000013
BSPBio_001572
BSPBio_001826
Bio1_000359
Bio1_000848
Bio1_001337
Bio2_000292
Bio2_000772
C06821
C6H8ClN7O
CCRIS 6545
CHEBI:2639
CHEMBL945
CID16231
CPD-10324
D07447
DB00594
DivK1c_000182
EINECS 220-024-7
Guanamprazin
 
Guanamprazine
HMS1791O14
HMS1989O14
HMS2089H05
IDI1_000182
IDI1_034042
KBio1_000182
KBio2_000292
KBio2_000394
KBio2_002860
KBio2_002962
KBio2_005428
KBio2_005530
KBio3_000583
KBio3_000584
KBio3_001326
KBioGR_000292
KBioGR_000544
KBioSS_000292
KBioSS_000394
LS-1094
Lopac-A-7410
Lopac0_000111
MK-870 (Hydrochloride dihydrate)
MLS000758249
MLS001060798
Midamor
Midamor (Hydrochloride dihydrate)
MolPort-005-934-472
MolPort-005-937-651
N-Amidino-3,5-diamino-6-chloropyrazinecarboxamide
N-Amidino-3,5-diamino-6-chlorpyrazincarboxamid
N-amidino-3,5-diamino-6-chloropyrazinecarboxamide
NCGC00015089-01
NCGC00015089-02
NCGC00015089-12
NCGC00024443-02
NCGC00024443-05
NCGC00024443-06
NCGC00024443-07
NCGC00024443-09
NINDS_000182
Prestwick0_000007
Prestwick1_000007
Prestwick2_000007
Prestwick3_000007
Pyrazinecarboxamide, 3,5-diamino-N-(aminoiminomethyl)-6-chloro-, monohydrochloride
SMR000449325
SMR000486264
SPBio_000136
SPBio_001934
ST079279
Spectrum2_000118
Spectrum3_000293
Spectrum4_000132
Spectrum5_000776
Spectrum_000034
Tocris-0890
UNII-7DZO8EB0Z3
ZINC04340269
30
Heparinapproved, investigational8489005-49-6772, 46507594
Synonyms:
101921-26-0
102-94-3
102785-31-9
104521-37-1
11078-24-3
11129-39-8
12656-11-0
2-o-sulfohexopyranuronosyl-(1->4)-2-deoxy-3-o-sulfo-2-(sulfoamino)hexopyranosyl-(1->4)-2-o-sulfohexopyranuronosyl-(1->4)-2-acetamido-2-deoxy-6-o-sulfohexopyranose
37324-73-5
6-[6-[6-[5-acetamido-4,6-dihydroxy-2-(sulfooxymethyl)oxan-3-yl]oxy-2-carboxy-4-hydroxy-5-sulfooxyoxan-3-yl]oxy-2-(hydroxymethyl)-5-(sulfoamino)-4-sulfooxyoxan-3-yl]oxy-3,4-dihydroxy-5-sulfooxyoxane-2-carboxylic acid
9041-08-1
9045-22-1
9075-96-1
913079-23-9
91449-79-5
AC1L19ZN
AC1L1ROY
ALFA 87-120
ALFA 87-163
ALFA 87-198
ALFA 87-81
ALFA 88-247
AR-1E4539
Allocinnamic acid
Ardeparin
Ardeparin sodium
Arteven
Bemiparin
Bemiparin sodium
CID772
CID8784
CY 216
Calciparine
Certoparin
Clexane
Clivarin
Clivarine
Cy 222
D006495
D017984
DB00407
DB01225
Dalteparin
Dalteparin sodium
Depo-Heparin
EINECS 232-681-7
EMT 966
EMT 967
EMT-966
EMT-967
EMT966
EMT967
Enoxaparin
Enoxaparin sodium
Enoxaparine
Eparina
Eparina [DCIT]
FR 860
Fluxum
Fragmin A
Fragmin B
Fragmin IV
Fraxiparin
H 2149
HSDB 3094
Hed-heparin
Hep Flush Kit in plastic container
Hep-Lock
Hep-Lock U/P
Hep-lock
Heparin
Heparin CY 216
Heparin Lock Flush
Heparin Lock Flush in plastic container
Heparin Lock Flush preservative free
Heparin Lock Flush preservative free in plastic container
Heparin Sodium
Heparin natrium
Heparin sodium
Heparin sodium 1,000 units and sodium chloride 0.9% in plastic container
Heparin sodium 1,000 units in dextrose 5% in plastic container
Heparin sodium 1,000 units in sodium chloride 0.9% in plastic container
Heparin sodium 10,000 units in dextrose 5%
Heparin sodium 10,000 units in dextrose 5% in plastic container
Heparin sodium 10,000 units in sodium chloride 0.45%
Heparin sodium 10,000 units in sodium chloride 0.9%
Heparin sodium 12,500 units in dextrose 5%
Heparin sodium 12,500 units in dextrose 5% in plastic container
Heparin sodium 12,500 units in sodium chloride 0.45% in plastic container
Heparin sodium 12,500 units in sodium chloride 0.9%
Heparin sodium 2,000 units and sodium chloride 0.9% in plastic container
Heparin sodium 2,000 units in dextrose 5% in plastic container
Heparin sodium 2,000 units in sodium chloride 0.9% in plastic container
Heparin sodium 20,000 units and dextrose 5% in plastic container
Heparin sodium 20,000 units in dextrose 5% in plastic container
Heparin sodium 25,000 units and dextrose 5% in plastic container
 
Heparin sodium 25,000 units in dextrose 5%
Heparin sodium 25,000 units in dextrose 5% in plastic container
Heparin sodium 25,000 units in sodium chloride 0.45% in plastic container
Heparin sodium 25,000 units in sodium chloride 0.9%
Heparin sodium 25,000 units in sodium chloride 0.9% in plastic container
Heparin sodium 5,000 units and sodium chloride 0.9% in plastic container
Heparin sodium 5,000 units in dextrose 5% in plastic container
Heparin sodium 5,000 units in sodium chloride 0.45%
Heparin sodium 5,000 units in sodium chloride 0.9%
Heparin sodium 5,000 units in sodium chloride 0.9% in plastic container
Heparin sodium in plastic container
Heparin sodium preservative Free
Heparin sulfate
Heparin sulphate
Heparin, Low Molecular Weight
Heparin, Low-Molecular-Weight
Heparin, sodium salt
Heparina
Heparina [INN-Spanish]
Heparinate
Heparine
Heparine [INN-French]
Heparinic acid
Heparinsodiumsalt
Heparinum
Heparinum [INN-Latin]
Heparinum natricum
Hepathrom
Hepflush-10
Inno-Hep
Innohep
Isocinnamic acid
KB 101
Kabi 2165
LHN 1
LMWH
Lioton 1000
Lipo-hepin
Liquaemin
Liquaemin Lock Flush
Liquaemin Sodium
Liquaemin sodium preservative free
Liquemin
Logiparin
Lovenox
Lovenox HP
Low Molecular Weight Heparin
Low molecular weight heparin
Low molecular weight heparin sodium
Low-Molecular-Weight Heparin
Minolteparin sodium
MolPort-003-760-257
Multiparin
NSC174025
Nadroparin
Nadroparine
Novoheparin
OP 386
OP 622
Octaparin
PK 10,169
PK-10,169
PK-10169
PK10,169
PK10169
Pabyrin
Panheprin
Parnaparin
Parnaparin sodium
Parvoparin
Pularin
Reviparin
Reviparin sodium
Ro 11
Sandoparin
Sodium acid heparin
Sodium heparin
Sodium heparinate
Subeparin
Sublingula
Thromboliquine
Tinzaparin
Tinzaparin sodium
Triofiban
UNII-12M44VTJ7B
UNII-3S182ET3UA
UNII-E47C0NF7LV
UNII-T2410KM04A
UNII-ZZ45AB24CA
Unfractionated heparin
Vetren
Vitrum AB
WY 90493RD
alpha-Heparin
cis-.beta.-Carboxystyrene
cis-Cinnamic acid
enoxaparin
heparin
31
Lidocaineapproved, vet_approved1317137-58-63676
Synonyms:
.alpha.-(Diethylamino)-2,6-acetoxylidide
.alpha.-Diethylamino-2,6-dimethylacetanilide
.alpha.-Diethylaminoaceto-2,6-xylidide
.omega.-Diethylamino-2,6-dimethylacetanilide
137-58-6
2-(Diethylamino)-2',6'-acetoxylidide
2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide
2-Diethylamino-N-(2,6-dimethyl-phenyl)-acetamide
2-Diethylamino-N-(2,6-dimethylphenyl)acetamide
4-12-00-02538 (Beilstein Handbook Reference)
6108-05-0 (MONOHYDROCHLORIDE MONOHYDRATE))
6108-05-0 (mono-hydrochloride, mono-hydrate)
73-78-9 (mono-hydrochloride)
AB00053581
AC-10282
AC1L1GGQ
AC1Q2Z7J
AKOS001026768
ARONIS23855
After Burn Double Strength Gel
After Burn Double Strength Spray
After Burn Gel
After Burn Spray
Alphacaine
Anestacon
Anestacon Jelly
BIDD:GT0342
BPBio1_000197
BRD-K52662033-001-02-6
BRD-K52662033-003-05-5
BRN 2215784
BSPBio_000179
BSPBio_001359
BSPBio_003004
Bio-0767
Bio1_000379
Bio1_000868
Bio1_001357
Bio2_000079
Bio2_000559
C07073
C14H22N2O
CAS-73-78-9
CDS1_000283
CHEBI:6456
CHEMBL79
CID3676
CPD000058189
Cappicaine
Cito optadren
Cuivasil
D00358
DB00281
Dalcaine
Dentipatch
Dentipatch (TN)
DermaFlex
Diethylaminoaceto-2,6-xylidide
Dilocaine
DivK1c_000174
DivK1c_001323
Duncaine
EINECS 205-302-8
ELA-Max
EMBOLEX
Emla
Emla Cream
Esracaine
FT-0082378
Gravocain
HMS1791D21
HMS1989D21
HMS2051C21
HMS2089E15
HMS548M19
HSDB 3350
I01-2704
IDI1_000174
IDI1_033829
Isicaina
Isicaine
Jetocaine
KBio1_000174
KBio2_000079
KBio2_001598
KBio2_002647
KBio2_004166
KBio2_005215
KBio2_006734
KBio3_000157
KBio3_000158
KBio3_002224
KBioGR_000079
KBioGR_000599
KBioSS_000079
KBioSS_001598
L-Caine
L0156
L1026_SIGMA
L7757_SIGMA
LIDOCAINE (73-58-6 (MONOHYDROCHLORIDE)
LIDOPEN
LQZ
 
LS-805
Lanabiotic
Leostesin
Lida-Mantle
Lidocaina
Lidocaina [INN-Spanish]
Lidocaine (JP15/USP/INN)
Lidocaine (VAN)
Lidocaine Carbonate
Lidocaine Hydrocarbonate
Lidocaine Monohydrochloride
Lidocaine [USAN:INN:JAN]
Lidocainum
Lidocainum [INN-Latin]
Lidocaton
Lidoderm
Lidoject-1
Lidoject-2
Lignocaine
Lignocainum
Lingocaine
Lopac-L-5647
Lopac0_000669
MLS000069724
MLS000758263
MLS001074177
Maricaine
Maybridge1_002571
MolPort-001-783-478
N-(2,6-dimethylphenyl)-N(2),N(2)-diethylglycinamide
N-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide
NCGC00015611-01
NCGC00015611-02
NCGC00015611-03
NCGC00015611-04
NCGC00015611-14
NCGC00022176-05
NCGC00022176-06
NCGC00022176-07
NCGC00022176-08
NCGC00022176-09
NINDS_000174
NSC 40030
NSC40030
Norwood Sunburn Spray
Octocaine
Octocaine-100
Octocaine-50
Prestwick0_000050
Prestwick1_000050
Prestwick2_000050
Prestwick3_000050
Remicaine
Rocephin Kit
Rucaina
S1357_Selleck
SAM001247018
SMR000058189
SPBio_001525
SPBio_002100
STK552033
Solarcaine
Solarcaine aloe extra burn relief cream
Solcain
Spectrum2_001343
Spectrum3_001392
Spectrum4_000070
Spectrum5_001549
Spectrum_001118
UNII-98PI200987
WLN: 2N2 & 1VMR B1 F1
Xilina
Xilocaina
Xilocaina [Italian]
Xllina
Xycaine
Xylestesin
Xylesthesin
Xylocain
Xylocaine
Xylocaine (TN)
Xylocaine 5% Spinal
Xylocaine CO2
Xylocaine Dental Ointment
Xylocaine Endotracheal
Xylocaine Test Dose
Xylocaine Viscous
Xylocaine-MPF
Xylocaine-MPF with Glucose
Xylocaine-Mpf
Xylocaine-Mpf with Glucose
Xylocard
Xylocitin
Xyloneural (free base)
Xylotox
Zilactin-L
Zingo
alfa-Dietilamino-2,6-dimetilacetanilide
alfa-Dietilamino-2,6-dimetilacetanilide [Italian]
alpha-Diethylamino-2,6-dimethylacetanilide
alpha-diethylamino-2,6-dimethylacetanilide
lidocaine
nchembio.65-comp16
α-diethylamino-2,6-dimethylacetanilide
32Mineralocorticoids367
33Sodium Channel Blockers1593
34Natriuretic Agents1697
35Mineralocorticoid Receptor Antagonists346
36Hormones, Hormone Substitutes, and Hormone Antagonists13168
37Diuretics, Potassium Sparing1917
38diuretics1418
39Epithelial Sodium Channel Blockers50
40Hormones14415
41Hormone Antagonists13180
42Fibrinolytic Agents2388
43Pharmaceutical Solutions8192
44Anesthetics, Local3492
45Angiotensin-Converting Enzyme Inhibitors724
46Anesthetics9596
47calcium heparin848
48Adrenergic beta-Antagonists1193

Interventional clinical trials:

(show all 21)
idNameStatusNCT IDPhase
1Revascularization of Renal Artery Stenosis Versus Medical Therapy for the Treatment of Ischemic NephropathyUnknown statusNCT01023373Phase 4
2Renal Stenting With Distal Atheroembolic ProtectionUnknown statusNCT00868972Phase 2, Phase 3
3Benefits of Medical Therapy Plus Stenting for Renal Atherosclerotic LesionsCompletedNCT00081731Phase 3
4Evaluation of Celecoxib Effects on Amlodipine in Subjects With Existing Hypertension Requiring AntihypertensivesRecruitingNCT02979197Phase 3
5Study to Assess the Effects of Intravenous Bendavia in Patients Undergoing Percutaneous Transluminal Angioplasty of the Renal Artery (PTRA)TerminatedNCT01755858Phase 1, Phase 2
6MRI to Detect Embolism Following Angiography and Angioplasty-Stenting of the Renal ArteryCompletedNCT00027469Phase 1
7Hypoxia and Inflammatory Injury in Human Renovascular HypertensionRecruitingNCT02266394Phase 1
8MSC for Occlusive Disease of the KidneyActive, not recruitingNCT01840540Phase 1
9Magnetic Resonance Imaging for Evaluating Kidney FunctionCompletedNCT00006173
10Renal Atherosclerotic Revascularization Evaluation: RAVE StudyCompletedNCT00127738
11Cross-sectional Study of Patients With Renal or Craniocervical Fibromuscular DysplasiaCompletedNCT02884141
12REFORM Clinical Study: Treatment of Renal Artery Stenosis With the Formula Balloon-Expandable StentCompletedNCT00631540
13The Effects of Amiloride and Spironolactone on Renophysiological and Cardiovascular VariablesCompletedNCT01195805
14Telehealth & Remote Measurement Technologies to Improve Medication Adherence in HypertensionCompletedNCT01439256
15A Prospective Danish National Registry of PTRA in Patients With Renovascular HypertensionRecruitingNCT02770066
16Renal Stent Placement for the Treatment of Renal Artery Stenosis in Patients With Resistant HypertensionRecruitingNCT01673373
17Cardiovascular, Renal and Metabolic Profile in Patients With Acute Myocardial Infarction (REN-ACS)RecruitingNCT02388139
18Evaluation of Patients With Heart Disease Not Eligible for Research ProtocolsRecruitingNCT00001458
19IntErnational Long-term Follow-up Study of Patients With Uncontrolled HyperTensioNActive, not recruitingNCT01705080
20A Feasibility Study to Evaluate the Effect of Concomitant Renal Denervation and Cardiac Ablation on AF RecurrenceActive, not recruitingNCT01907828
21Endovascular Therapy for Renal Artery Stenosis in ChinaNot yet recruitingNCT03080519

Search NIH Clinical Center for Renovascular Hypertension

Inferred drug relations via UMLS68/NDF-RT46:


Cochrane evidence based reviews: hypertension, renovascular

Genetic Tests for Renovascular Hypertension

About this section

Anatomical Context for Renovascular Hypertension

About this section

MalaCards organs/tissues related to Renovascular Hypertension:

36
Kidney, Endothelial, Testes, Heart, Liver, Brain, Monocytes

Publications for Renovascular Hypertension

About this section

Articles related to Renovascular Hypertension:

(show top 50)    (show all 649)
idTitleAuthorsYear
1
Complex glomerular pathology of thrombotic microangiopathy and focal segmental glomerulosclerosis forms tumor-like mass in a renal transplant donor with severe renovascular hypertension. (28509120)
2017
2
Tempol improves xanthine oxidoreductase-mediated vascular responses to nitrite in experimental renovascular hypertension. (27078869)
2016
3
Impaired Neovascularization and Reduced Capillary Supply in the Malignant vs. Non-malignant Course of Experimental Renovascular Hypertension. (27625610)
2016
4
Imperatorin derivative OW1 inhibits the upregulation of TGF-I^ and MMP-2 in renovascular hypertension-induced cardiac remodeling. (27168797)
2016
5
Management of Renovascular Hypertension. (27641455)
2016
6
Infantile Renovascular Hypertension with Failure to Thrive. (26965798)
2016
7
Takayasu arteritis associated with severe renovascular hypertension. (26997400)
2016
8
Antagonism of endothelin (ETA and ETB) receptors during renovascular hypertension-induced vascular dementia improves cognition. (27189349)
2016
9
Exercise training attenuates renovascular hypertension partly via RAS- ROS- glutamate pathway in the hypothalamic paraventricular nucleus. (27881877)
2016
10
Aliskiren and l-arginine treatments restore depressed baroreflex sensitivity and decrease oxidative stress in renovascular hypertension rats. (27383506)
2016
11
Percutaneous Transluminal Angioplasty Improved Posterior Reversible Encephalopathy Syndrome due to Renovascular Hypertension. (26646732)
2016
12
Blockade of CCR2 reduces macrophage influx and development of chronic renal damage in murine renovascular hypertension. (26661648)
2016
13
Cardiovascular manifestations of renovascular hypertension in diabetic mice. (26925344)
2016
14
Homocysteine and hydrogen sulfide in epigenetic, metabolic and microbiota related renovascular hypertension. (27602985)
2016
15
OS 11-03 Role of renal nervous activity in the development of renovascular hypertension in rats. (27753970)
2016
16
Aortic Intimal Sarcoma Contributes to Atherosclerotic Renovascular Hypertension: An Autopsy Case Report and Review of the Literature. (27041160)
2016
17
Regular exercise alleviates renovascular hypertension-induced cardiac/endothelial dysfunction and oxidative injury in rats. (27010894)
2016
18
Large retroperitoneal immature teratoma leading to renovascular hypertension. (28008730)
2016
19
Novel insights into renovascular hypertension and cardio-renal protection by iron restriction. (27604341)
2016
20
Hypercholesterolemia Impairs Nonstenotic Kidney Outcomes After Reversal of Experimental Renovascular Hypertension. (26739189)
2016
21
Renovascular hypertension: Effects of mesenchymal stem cells in the contralateral hypertensive kidney in rats. (27649588)
2016
22
Outcomes of percutaneous transluminal angioplasty for pediatric renovascular hypertension. (27634559)
2016
23
BehAset's Disease Presenting as Renovascular Hypertension Treated Successfully With Percutaneous Angioplasty. (27916225)
2016
24
Resveratrol improves vasoprotective effects of captopril on aortic remodeling and fibrosis triggered by renovascular hypertension. (26764145)
2016
25
OS 11-03 Role of renal nervous activity in the development of renovascular hypertension in rats. (27643367)
2016
26
Non-invasive imaging cannot replace formal angiography in the diagnosis of renovascular hypertension. (27747454)
2016
27
Therapeutic evaluation of rutin in two-kidney one-clip model of renovascular hypertension in rat. (26920631)
2016
28
Carotid sinus denervation ameliorates renovascular hypertension in adult Wistar rats. (27510951)
2016
29
Prior renovascular hypertension does not predispose to atherosclerosis in mice. (27100924)
2016
30
Decreased immunoreactivity of visfatin in the pancreas and liver of rats with renovascular hypertension. (28078856)
2016
31
Estrogen receptor agonists alleviate cardiac and renal oxidative injury in rats with renovascular hypertension. (27399230)
2016
32
Restoration of Mitochondrial Cardiolipin Attenuates Cardiac Damage in Swine Renovascular Hypertension. (27247333)
2016
33
Selective stent placement versus balloon angioplasty for renovascular hypertension caused by Takayasu arteritis: Two-year results. (26730842)
2016
34
Attenuation of renovascular hypertension by cyclooxygenase-2 inhibitor partly through ANP release. (25846103)
2015
35
Influence of renovascular hypertension on the distribution of vasoactive intestinal peptide in the stomach and heart of rats. (25990439)
2015
36
Iliac artery obliteration as a cause of renovascular hypertension in kidney graft recipients: A difficult and uncommon diagnosis. (26306960)
2015
37
Angioplasty for renovascular hypertension in 78 children. (25527520)
2015
38
Sildenafil Improves Vascular Endothelial Structure and Function in Renovascular Hypertension. (26059106)
2015
39
Brain Stem Hemorrhage in a 2-Year-10-Month-Old Child with Renovascular Hypertension Related to Fibromuscular Dysplasia. (27122924)
2015
40
Combined aliskiren and L-arginine treatment has antihypertensive effects and prevents vascular endothelial dysfunction in a model of renovascular hypertension. (25493385)
2015
41
Combined Aliskiren and L-arginine treatment reverses renovascular hypertension in an animal model. (25740291)
2015
42
Quantitative evaluation of CART-containing cells in urinary bladder of rats with renovascular hypertension. (26150151)
2015
43
Detection of Segmental Renal Ischemia by Diffusion-Weighted Magnetic Resonance Imaging: Clinical Utility for Diagnosis of Renovascular Hypertension. (26360321)
2015
44
Effect of naringin on hemodynamic changes and left ventricular function in renal artery occluded renovascular hypertension in rats. (25883516)
2015
45
Aldosterone Contributes to Sympathoexcitation in Renovascular Hypertension. (25628418)
2015
46
Effects of mesenchymal stem cells in renovascular hypertension. (25605443)
2015
47
Impact of Small Renal Ischemia in Hypertension Development: Renovascular Hypertension Caused by Small Branch Artery Stenosis. (26293888)
2015
48
Associated extrarenal vascular diseases may complicate the treatment andA outcome of renovascular hypertension. (26437121)
2015
49
Retrograde Renal Ablation via the Renal Vein as a New Treatment Option for Renovascular Hypertension. (25812711)
2015
50
Gastric S-nitrosothiol formation drives the antihypertensive effects of oral sodium nitrite and nitrate in a rat model of renovascular hypertension. (26159506)
2015

Variations for Renovascular Hypertension

About this section

Expression for genes affiliated with Renovascular Hypertension

About this section
Search GEO for disease gene expression data for Renovascular Hypertension.

Pathways for genes affiliated with Renovascular Hypertension

About this section

GO Terms for genes affiliated with Renovascular Hypertension

About this section

Cellular components related to Renovascular Hypertension according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1extracellular regionGO:00055768.0ACE, ADM, CMA1, EDN1, NPPA, NPPB
2extracellular spaceGO:00056157.4ACE, ADM, EDN1, HMOX1, NPPA, NPPB

Biological processes related to Renovascular Hypertension according to GeneCards Suite gene sharing:

(show all 32)
idNameGO IDScoreTop Affiliating Genes
1beta-amyloid metabolic processGO:005043510.6ACE, REN
2blood vessel remodelingGO:000197410.5ACE, NOS3
3phosphatidylinositol 3-kinase signalingGO:001406510.4EDN1, NF1
4regulation of systemic arterial blood pressure by endothelinGO:000310010.4EDN1, NOS3
5negative regulation of extrinsic apoptotic signaling pathway via death domain receptorsGO:190204210.3HMOX1, NOS3
6renin-angiotensin regulation of aldosterone productionGO:000201810.3AGTR1, REN
7regulation of systemic arterial blood pressure by renin-angiotensinGO:000308110.3ACE, AGTR1
8positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathwayGO:005148210.3AGTR1, EDN1
9regulation of angiogenesisGO:004576510.3HMOX1, NF1
10response to muscle stretchGO:003599410.2EDN1, NPPA
11kidney developmentGO:000182210.1ACE, AGTR1, REN
12cGMP biosynthetic processGO:000618210.1NPPA, NPPB
13body fluid secretionGO:000758910.0EDN1, NPPB
14angiotensin maturationGO:000200310.0ACE, CMA1, REN
15receptor guanylyl cyclase signaling pathwayGO:000716810.0NPPA, NPPB
16positive regulation of renal sodium excretionGO:003581510.0EDN1, NPPB
17positive regulation of urine volumeGO:003581010.0EDN1, NPPB
18positive regulation of heart rateGO:001046010.0ADM, EDN1, NPPA
19regulation of vasoconstrictionGO:001922910.0ACE, AGTR1, EDN1
20heart developmentGO:00075079.9ADM, EDN1, NF1
21response to lipopolysaccharideGO:00324969.8ADM, EDN1, REN
22positive regulation of vasodilationGO:00459099.8ADM, HMOX1, NOS3
23positive regulation of cytosolic calcium ion concentrationGO:00072049.8ADM, AGTR1, EDN1
24smooth muscle hyperplasiaGO:00148069.6HMOX1, NOS3
25response to nicotineGO:00350949.6EDN1, HMOX1
26regulation of blood vessel diameterGO:00977469.5ACE, AGTR1, NPPB
27regulation of vasodilationGO:00423129.5ACE, AGTR1, NPPB
28negative regulation of cell proliferationGO:00082859.4ADM, HMOX1, NF1, NOS3
29regulation of blood vessel sizeGO:00508809.3EDN1, NOS3, NPPA, NPPB
30positive regulation of angiogenesisGO:00457669.2ADM, CMA1, HMOX1, NOS3
31response to hypoxiaGO:00016669.0ADM, EDN1, HMOX1, NF1, NPPA
32regulation of blood pressureGO:00082178.2ACE, EDN1, HMOX1, NOS3, NPPA, NPPB

Molecular functions related to Renovascular Hypertension according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1bradykinin receptor bindingGO:003171110.3ACE, AGTR1
2endopeptidase activityGO:00041759.9ACE, CMA1, REN
3hormone activityGO:00051799.1ADM, EDN1, NPPA, NPPB
4receptor bindingGO:00051028.2ADM, EDN1, NPPA, NPPB, REN

Sources for Renovascular Hypertension

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet